Dietary Supplements for Longevity Round-table Notes
Participants & Context
- Panelists: Nick (Physionic), Siim (Siimland), Greg Potter (host)
- Theme: Dietary supplements & drugs for lifespan and healthspan extension
- Format: Lightning-round questions ➜ deep-dive discussion on evidence, mechanisms, safety, timing, personal practice
Hypothetical “Give-Everyone-Two” Exercise
Rules
- Adults ≥30 y, unlimited budget, body-weight–adjusted dosing allowed
- Panelists pick up to 2 nutraceuticals/drugs for population-wide distribution
Picks
Speaker | Pick #1 | Pick #2 (± extras) | Key Rationale |
---|
Nick | Creatine (monohydrate) | Rapamycin (or Metformin as cheaper fallback) | Creatine = universal brain & muscle support; Rapamycin = most robust pro-longevity data in mammals |
Siim | Creatine | High-quality omega-3 (EPA + DHA) • If drug allowed: Acarbose / Metformin / Rapamycin | Omega-3 ➜ cardiovascular & neuro benefits, anti-inflammatory; glucose-lowering drugs address population-wide dysglycaemia |
Greg | Creatine | Low-dose GLP-1 receptor agonist (e.g., Semaglutide) | GLP-1s tackle weight & glycaemia; creatine offsets sarcopenia risk |
Underrated / Under-Recognised Agents
Supplements / Nutraceuticals
- Taurine : BP ↓, metabolic & exercise benefits, cheap & safe
- Curcumin : ↓ blood sugar, anti-arthritic, anti-inflammatory
- Lutein + Zeaxanthin : ocular & brain health; carotenoids accumulate in retina
- Astaxanthin : senolytic, UV-skin protection, ↓ inflammation, lifespan ↑ (12 % in ITP mice)
- Glucosamine (sulfate) : joint & potential longevity signal (epidemiology)
Single Underrated Drug (forced choice)
- Nick → GLP-1 RAs (potency > pill-fear stigma)
- Siim → Acute BP meds (short-term safety > hypertension risk) ± Metformin/Acarbose
- Greg → PDE-5 inhibitors (Sildenafil/Tadalafil) for vascular, brain & QoL benefits
Evaluation Framework for Geroprotectors
- Evidence bar
- Lifespan/healthspan data in ≥2 model species
- Human mechanistic markers and functional outcomes (grip, VO2, bloods)
- Hallmarks tackled (e.g., mitochondrial dysfunction, senescence, nutrient sensing)
- Effect size & population (bigger effect in sicker/older groups)
- Safety / cost / sourcing
- Third-party testing (ConsumerLab, Informed-Sport)
- Beware proprietary blends & under-dosing (e.g., NMN on Amazon: only ~15 % meet label)
- Contaminants (drug analogues, plastics in fibre powders)
- Form & bioavailability
- Curcumin (BioCurc > turmeric); Rhodiola rosavins:salidroside ratio; Mg citrate ≠ Mg oxide
- Timing variables
- Circadian phase (sleep aids p.m.; stimulants a.m.)
- Training days vs. rest (metformin, rapamycin, senolytics best on rest days)
- Life-stage (creatine for elders, berberine for 60 + dysglycaemia, senolytics late-life)
- Interactions
- Exercise: High-dose Vit C/E, NAC, metformin may blunt hypertrophy / VO2 gains
- Diet: tannins inhibit Fe absorption; calorie restriction mimetics redundant in CR dieters
- Genetics: MTNR1B variant → exaggerated glucose rise on melatonin
- Drugs: Piperine inhibits CYP3A4 etc.
Classic Essential-Nutrient Supplements (Quick Takes)
Omega-3 (EPA + DHA)
- 1 g/d in algae oil RCT ↓ epigenetic “Pace of Aging” (Horvath study, 70-y cohort)
- Brain, CV & anti-inflam; higher dosed for triglyceride lowering (≥2–4 g EPA-only)
Vitamin D3 ± K2
- Sun << supplements in high-melanin + high-latitude populations
- Hyper-dosing (≥50,000 IU) risks hypercalcaemia; aim to maintain 50–100\,\text{nmol·L}^{-1}
Multivitamins
- COSMOS trial: small cognitive retention after 3 y
- Benefits scale inversely with diet quality; men vs. pre-menopausal women need different Fe, etc.
Deep-Dive on Specific Geroprotectors
1. NAD Boosters
Agent | Data Summary | Issues |
---|
NMN / NR | ↑ blood NAD; heterogeneous tissue response; no lifespan in ITP; human RCTs ⇢ modest ↓ inflammation, BP in pre-disease | FDA removed NMN supplement status (drug path); ≥1{,}000\,\text{mg/d} cost-prohibitive |
“Systems approach” (Tru Niagen / Cheetah “Time”) | Combine \text{NAM}+\text{EGCG}+\text{Rutin}+\text{Parsley Ext.} to ↑ salvage & ↓ CD38 | 28-d RCT: small NAD rise; stats criticised (no multiple-test correction) |
Trigonelline | Coffee alkaloid; boosts muscle NAD in rodents | Human data pending |
Ergothioneine | Mushroom amino acid (see later) markedly ↑ NAD via different route | |
2. Resveratrol
- Early hype (Sinclair, SIRT1) ➜ French paradox claim
- Lifespan only in obese, coconut-oil-fed mice
- ↓ BP, glucose in diabetics; possible ↓ VO2 and androgens; cost vs. benefit modest
3. Lithium (micro-dose \approx0.3–1\,\text{mg/d})
- Ecological data: higher water Li → ↓ suicide, homicide, ↑ longevity
- Human micro-RCTs: slowed cognitive decline in MCI; neuroprotective; safety good at trace doses
4. Alpha-Ketoglutarate (AKG)
- Calcium-AKG (Rejuvant) 2 g time-release: retrospective 6-mo ↓ epigenetic age ~7 y
- Animal: +12–16 % median lifespan (f > m)
- Ongoing AEL RCT (grip, BP, inflamm.)
- Mechanisms: Krebs intermediate, stem-cell niche, collagen synthesis
5. Glycine & GLYC (Glycine + N-Acetyl-Cysteine)
- ITP: +4–6 % lifespan both sexes (methionine-glycine balance)
- Human: 3\,\text{g} pre-bed → ↑ sleep quality; 100\,\text{mg·kg}^{-1} GLYC in 70-y adults → ↑ glutathione, ↓ CRP, ↓ HOMA-IR, ↑ gait & grip
- Safe, sweet-tasting, inexpensive
6. Taurine
- Blood taurine ↓ 80 % from youth → 60 y
- Science 2023 multi-species paper: taurine repletion ↔ ↓ DNA damage, ↑ stem cell function, ↑ lifespan; supportive macaque data
- Human RCTs (6 g/d) ↓ BP, ↑ insulin sensitivity; exercise ergogenic
7. Ergothioneine
- Concentrated in oyster/king oyster mushrooms; transporter OCTN-1 allows tissue accumulation
- Pre-clinical: anti-oxidant, mito-protective, ↑ NAD, neuro- & cardio-protective; lifespan extension in C. elegans, mice (high dose)
- Early human trials: 5–25 mg/d underway; safety promising
8. Astaxanthin
- ITP: +12 % (mice)
- Human: UV-skin defence, ↓ triglycerides, ↑ endurance, potential fertility boost
- Typical dose 4–12\,\text{mg/d}; from Haematococcus pluvialis micro-algae; fat-soluble (take with meal)
9. Rapamycin & Exercise Interactions
- Inhibits mTORC1; lifespan ↑ in multiple species
- Concerns: may blunt muscle hypertrophy & immunity; pragmatic approach = weekly dose on non-training days
- ↓ VO2-max & mitochondrial adaptation to endurance training; beneficial for pre-diabetes/metabolic syndrome; rotate with training schedule
11. Urolithin A
- Mitophagy activator (pomegranate ellagitannin metabolite)
- Timeline Nutrition RCTs: only hamstring torque ↑; grip & endurance NS after 6 mo
- Cost >8\,\$\,\text{/day} at efficacious 1 g dose
12. Nobiletin
- Citrus peel polymethoxy-flavone; clocks re-alignment agent
- Takahashi lab: restores circadian amplitude; improves obesity & metabolic health in aged mice; human data awaited
Exercise–Supplement Interaction Cheat-Sheet
Category | Supps | Potential Conflict | Mitigation |
---|
Antioxidants | \ge2\,\text{g} Vit C, 400 IU Vit E, NAC | ↓ ROS signaling ➜ ↓ hypertrophy / VO2 gains | Use food doses; avoid peri-workout mega-doses |
Glucose mimetics | Metformin, Berberine | ↓ mitochondrial biogenesis | Dose on rest days |
mTOR inhibitors | Rapamycin | Possible ↓ protein synthesis | Weekly pulse; not on lifting days |
Senolytics | Fisetin, Quercetin + Dasa | Theoretical wound-healing impairment | Use intermittently in later life |
Timing & Life-Stage Guidelines
- Morning: majority of pills for adherence; stimulants; fat-solubles with breakfast lipids
- Evening/Pre-sleep: Glycine, Taurine, Melatonin, Magnesium bisglycinate
- Mid-life (40-60 y): Begin omega-3 focus, BP control, glucose moderators if biomarkers drifting
- Late-life (60 +): Creatine 5\,\text{g}, GLYC \approx15\,\text{g} combo, Senolytics pulses, low-dose Rapamycin
Practical Purchasing Checklist
- Verify COA (certificate of analysis)
- Dose math: match RCT dose (e.g., Taurine 6\,\text{g} > typical 500 mg capsules)
- Form: e.g.
- Astaxanthin esterified oil softgel
- Calcium-AKG sustained-release tablets
- Avoid: Proprietary blends without per-ingredient weight; “fairy-dust” actives
- Batch test if athlete (WADA list)
Anecdotes & Miscellany
- Nick’s 3-h bodybuilding workouts & 90 lb weight gain ➜ “stupidest health phase”
- Siim crushed wardrobe doing lockdown pull-ups; confiscated caffeine powder at school
- Fun polls: AG1 vs. IM-08 vs. lose 30 → Nick would rather lose 30 than fund ads; Siim picks IM-08 (transparent labelling)
- “Is Brian Johnson healthiest man alive?” → Blood marker cherry-picking; impossible claim
Emerging “Watch List” Compounds
- C15:0 fatty acid (pentadecanoic) – low evidence, high marketing
- MPST-targeted ergothioneine derivatives – pending human work
- Senomorphic molecules (e.g., 17α-estradiol, sildenafil in ITP pipeline)
- Clock-modulators (REV-ERB agonists, nobiletin)
- GLYC effective dose \approx100\,\text{mg·kg}^{-1}\,(\text{glycine}+\text{NAC})
- Creatine maintenance 3–5\,\text{g/d}; loading 20\,\text{g/d} × 5 d
- Rapamycin trial pulses 5–10\,\text{mg weekly} (human off-label practice)
- Taurine lifespan mouse → human equivalent \sim3–6\,\text{g/d} (70 kg)
- Omega-3 CV dose \ge4\,\text{g EPA\/d}; general 1\,\text{g EPA+DHA}
Take-Home Heuristics
- Fix diet, sleep, exercise first; supps = 5–10 % gain
- Start cheap, proven, safe: Creatine, Omega-3, Magnesium, Glycine/Taurine
- Escalate with age & biomarkers: Metformin, AKG, Rapamycin pulses, GLYC
- Continuously reassess: new RCTs, personal labs, side-effects
- Personalisation matters: genotype, sex, baseline status, medication stack, circadian pattern
“The people most likely to take a multivitamin are the least likely to need it.” – Greg Potter